Haploinsufficiency of the Shank3 gene, which encodes a scaffolding protein at glutamatergic synapses, is a highly prevalent and penetrant risk factor for autism. Using combined behavioral, electrophysiological, biochemical, imaging, and molecular approaches, we find that Shank3-deficient mice exhibit autism-like social deficits and repetitive behaviors, as well as the significantly diminished NMDA receptor (NMDAR) synaptic function and synaptic distribution in prefrontal cortex. Concomitantly, Shank3-deficient mice have a marked loss of cortical actin filaments, which is associated with the reduced Rac1/PAK activity and increased activity of cofilin, the major actin depolymerizing factor. The social deficits and NMDAR hypofunction are rescued by inhibiting cofilin or activating Rac1 in Shank3-deficient mice and are induced by inhibiting PAK or Rac1 in wild-type mice. These results indicate that the aberrant regulation of synaptic actin filaments and loss of synaptic NMDARs contribute to the manifestation of autism-like phenotypes. Thus, targeting actin regulators provides a strategy for autism treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464902PMC
http://dx.doi.org/10.1016/j.celrep.2015.04.064DOI Listing

Publication Analysis

Top Keywords

shank3-deficient mice
16
targeting actin
8
actin regulators
8
social deficits
8
actin filaments
8
mice
5
actin
5
autism-like deficits
4
shank3-deficient
4
deficits shank3-deficient
4

Similar Publications

Article Synopsis
  • The study investigates the impact of Shank3 deficiency on dopaminergic neurons in mouse models relevant to autism.
  • Significant reductions in neurite outgrowth and altered morphology of dopaminergic neurons were observed in Shank3-deficient mice compared to wild-type (WT) mice.
  • Although there were no changes in the expression of synaptic proteins, shifts in dopaminergic receptor gene expression suggest structural alterations may contribute to autistic symptoms in these models.
View Article and Find Full Text PDF

Abnormalities in gamma-aminobutyric acid (GABA)ergic neurotransmission play a role in the pathogenesis of autism, although the mechanisms responsible for alterations in specific brain regions remain unclear. Deficits in social motivation and interactions are core symptoms of autism, likely due to defects in dopaminergic neural pathways. Therefore, investigating the morphology and functional roles of GABAergic neurons within dopaminergic projection areas could elucidate the underlying etiology of autism.

View Article and Find Full Text PDF

MDMA enhances empathy-like behaviors in mice via 5-HT release in the nucleus accumbens.

Sci Adv

April 2024

Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.

MDMA (3,4-methylenedioxymethamphetamine) is a psychoactive drug with powerful prosocial effects. While MDMA is sometimes termed an "empathogen," empirical studies have struggled to clearly demonstrate these effects or pinpoint underlying mechanisms. Here, we paired the social transfer of pain and analgesia-behavioral tests modeling empathy in mice-with region-specific neuropharmacology, optogenetics, and transgenic manipulations to explore MDMA's action as an empathogen.

View Article and Find Full Text PDF
Article Synopsis
  • - Synaptic dysfunction plays a crucial role in SHANK-associated disorders like autism, schizophrenia, and Phelan-McDermid syndrome, but understanding its effects on synaptic structure is limited.
  • - The study used advanced imaging techniques (expansion and STED microscopy) to examine the synaptic nanostructures in both human and mouse brain tissues, focusing on SHANK3-KO mice.
  • - Findings revealed unique shape profiles of murine postsynaptic scaffolds and significant changes in the organization of synaptic domains due to SHANK3 deficiency, shedding light on the molecular mechanisms of synaptic dysfunction in neuropsychiatric disorders.
View Article and Find Full Text PDF

Shank3 Deficiency Results in a Reduction in GABAergic Postsynaptic Puncta in the Olfactory Brain Areas.

Neurochem Res

April 2024

Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, 845 05, Slovakia.

Dysfunctional sensory systems, including altered olfactory function, have recently been reported in patients with autism spectrum disorder (ASD). Disturbances in olfactory processing can potentially result from gamma-aminobutyric acid (GABA)ergic synaptic abnormalities. The specific molecular mechanism by which GABAergic transmission affects the olfactory system in ASD remains unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!